17.0 REFERENCKS 
Afonso, L.C.C., Scharton, T.M., Vieira, L.Q., Wysocka, M., Trincnieri, G., 
Scott, P. The adjuvant effect of Interleukin-12 in a vaccine against Leishmania 
major. Science (Washington DC) 263: 235-237, 1994. 
Brunda, M.J., Luistro, L., Warrier, R.R., Wright, R.B., Hubbard, B.R., Murphy, 
Wolf, S.F., and Gately, M.K. Antitumor cmd antimetastatic activity of 
interleukin-12 against murine tumors. J. Ex. Med. 178: 1223-1230, 1993 
Chan, S.H., Perussia, B., Gupta, J.W., Kobayashi, M., Pospisil, M., Young, H.A., 
Wolf, S.F., Young, D., Clark, S.C., and Trinchieri, G. Induction of Interferon-g 
production by natural killer cell stimulatory factor: Characterization of the 
responder cells and synergy with other inducers. J. Exp. Med., 173: 869-879, 
1991. 
Culver, K.W., Ram, Z., Wallbridfe, S., Ishii, H., Oldfield, E. H., and Blease, 
R.M. Jn vivo gene transfer with retroviral vector-producer cells for treatment 
of experimental brains tumors. Science (Washington DC) 256: 1550-1552, 1992. 
Danos, 0. and Mulligan, R.C., Safe and efficient generation of recombinant 
retroviruses with amphotropic and ecotropic host ranges Proc . Natl. Acad. Sci. 
USA 85, 6460-6464, 1988. 
Fearon, E.R., Pardoll D.M., Itaya T. , Golumbek , Levits)cy H.I., Simons J.W., 
Karasuyama H., Vogelstein B., and Frost P. Interleukin-2 production by tumor 
cells bypass T helper function in the generation of an antitumor response. Cell, 
60: 397-403, 1990. 
Gansbacher B., Zeier, K., Daniels B., Cronin K., Benner ji R., and Gilboa E. 
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and 
induces protective immunity. J. Exp. Med., 172: 1217-1224, 1990. 
Gately M.K., Desai B.B., Wolitzky A.G., Quinn P.M., Dwyer C.M., Podlaski F.J., 
Familletti P.C., Sinigalia F, Chizzonite R., Gubler U., and Stern A.S. 
Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 
(cytotoxic lymphocyte maturation factor). J. Immunol., 147: 874-882,1991. 
Gately M.K., Warrier, R.R., Honasoge, S., Faherty, D.A., Connaughton, S.E., 
Anderson, T.D., Sarmiento, U., Hubbard, B.R., Murphy, M. Administration of 
recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and 
induces production of IFN-g in vivo. International Immunology (in press) 
Gubler U., Chua A.O., Schoenhout D.S., Dwyer C.M., McComas W., Motyka R., 
Nabavi N., Wolitzky A.G., Quinn P.M., Familletti P.C., and Gately M.K. 
Coexpression of two distinct genes is required to generate secreted bioactive 
cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA., 88: 4143- 
4147, 1991. 
Hsieh C-S, Macatonia S, Tripp C, Wolf S, O'Garra A, Murphy K. Development of Thl 
CD4+ T Cells through IL-12 Produced by Listeria-Induced Macrophages. Science, 
260: 547-549, 1993. 
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R.M., Clark, S.C., Chang, S-, Loudon, 
R., Sherman, F., Perussia, B., and Trinchieri, G. Identification and 
purification of natural killer cell stimulatory factor (NKSF) , a cytokine with 
multiple biologic effects on human lymphocytes. J Exp. Med., 170: 827-845, 1989. 
Recombinant DNA Research, Volume 19 
[663] 
